Eligibility Asthma NCT00562991

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00562991
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female children, aged 6-14 years
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
a documented history of asthma for a period of at least 6 months
Descripción

asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0040223
mild to severe persistent asthma according to gina guidelines
Descripción

mild to severe persistent asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2945599
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C3266628
a documented history of allergic sensitization (positive skin prick test or specific ige
Descripción

allergic sensitization

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3662483
UMLS CUI [2]
C0430561
subject's guardian/parent should be able to complete a symptom score on behalf of the subject.
Descripción

subject's guardian/parent should be able to complete a symptom score on behalf of the subject

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
subject's guardian/parent should be able to send a symptom score weekly by sms
Descripción

subject's guardian/parent should be able to send a symptom score weekly by sms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
both parents have to give written informed consent to participate in the study
Descripción

written informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
received any investigational study medication in the 4 weeks prior to screening visit
Descripción

investigational drug

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0040223
significant comorbidity such as concurrent infection, history of prematurity, history of bronchopulmonary dysplasia, cystic fibrosis, other chronic lung diseases, and other severe chronic diseases
Descripción

significant comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
acute asthma exacerbation within 4 weeks of screening visit
Descripción

asthma exacerbation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0349790
UMLS CUI [1,2]
C0040223
hospitalization within 12 weeks of screening visit
Descripción

hospitalization

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0040223
systemic corticosteroids within 12 weeks of screening visit
Descripción

systemic corticosteroids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4039704
oral corticosteroid dependence
Descripción

oral corticosteroid dependence

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0442027
UMLS CUI [1,3]
C0439857

Similar models

Eligibility Asthma NCT00562991

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00562991
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
male or female children, aged 6-14 years
boolean
C0001779 (UMLS CUI [1])
asthma
Item
a documented history of asthma for a period of at least 6 months
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
mild to severe persistent asthma
Item
mild to severe persistent asthma according to gina guidelines
boolean
C2945599 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C3266628 (UMLS CUI [1,3])
allergic sensitization
Item
a documented history of allergic sensitization (positive skin prick test or specific ige
boolean
C3662483 (UMLS CUI [1])
C0430561 (UMLS CUI [2])
subject's guardian/parent should be able to complete a symptom score on behalf of the subject
Item
subject's guardian/parent should be able to complete a symptom score on behalf of the subject.
boolean
C1321605 (UMLS CUI [1])
subject's guardian/parent should be able to send a symptom score weekly by sms
Item
subject's guardian/parent should be able to send a symptom score weekly by sms
boolean
C1321605 (UMLS CUI [1])
written informed consent
Item
both parents have to give written informed consent to participate in the study
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
investigational drug
Item
received any investigational study medication in the 4 weeks prior to screening visit
boolean
C0013230 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
significant comorbidity
Item
significant comorbidity such as concurrent infection, history of prematurity, history of bronchopulmonary dysplasia, cystic fibrosis, other chronic lung diseases, and other severe chronic diseases
boolean
C0009488 (UMLS CUI [1])
asthma exacerbation
Item
acute asthma exacerbation within 4 weeks of screening visit
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
hospitalization
Item
hospitalization within 12 weeks of screening visit
boolean
C0019993 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
systemic corticosteroids
Item
systemic corticosteroids within 12 weeks of screening visit
boolean
C4039704 (UMLS CUI [1])
oral corticosteroid dependence
Item
oral corticosteroid dependence
boolean
C0001617 (UMLS CUI [1,1])
C0442027 (UMLS CUI [1,2])
C0439857 (UMLS CUI [1,3])